Heart failure
Adult: Loading dose: 750 mcg/kg by slow inj over 2-3 min (may be repeated after 30 minutes if necessary). Maintenance: 5-10 mcg/kg/min by infusion. Max cumulative dose: 10 mg/kg in 24 hr.
Chỉ định và Liều dùng
Intravenous
Heart failure Adult: Loading dose: 750 mcg/kg by slow inj over 2-3 min (may be repeated after 30 minutes if necessary). Maintenance: 5-10 mcg/kg/min by infusion. Max cumulative dose: 10 mg/kg in 24 hr.
|
Tương kỵ
Incompatible with glucose-containing solutions and furosemide.
|
Chống chỉ định
Hypersensitivity.
|
Thận trọng
Obstructive pulmonary or aortic disease, hypertrophic cardiomyopathy; BP and heart rate monitored during drug administration; fluid and electrolyte balance should be maintained; platelet counts and liver function should be monitored; protect amp from light. Pregnancy and lactation.
|
Tác dụng không mong muốn
GI disturbances, nausea, vomiting, thrombocytopaenia, hypotension, chest pain, hypersensitivity, myositis, vasculitis, nail discoloration, Inj site pain, decreased tear production.
Potentially Fatal: Cardiac arrhythmia, hepatotoxicity. |
IV/Parenteral: C
|
Quá liều
May result in severe hypotension. General supportive and symptomatic treatment, including circulatory support, should also be initiated as necessary.
|
Tương tác
Chemical interaction with precipitation occurs with amrinone and dextrose or furosemide. Thus drug mixing should be avoided.
Potentially Fatal: Concurrent usage with disopyramide may lead to severe hypotension. |
Tác dụng
Description:
Mechanism of Action: Amrinone is a phosphodiesterase inhibitor which has vasodilating and positive inotropic properties. It causes an increase in cyclic adenosine monophosphate conc leading to greater contractile force in cardiac muscle. Pharmacokinetics: Distribution: 10-22% bound to plasma proteins. Half-life after IV admin: 4-6 hr. Metabolism: Partially metabolised in liver. Excretion: 40% excreted unchanged. |
Bảo quản
Store at 15-30°C.
|
Phân loại MIMS
|